21st Century Pharmacovigilance: Intuition, Science, and the Role of Artificial Intelligence
Peter J. Pitts
President, Center for Medicine in the Public Interest
DOI:https://doi.org/10.5912/jcb766
Abstract:
In an environment of real world evidence, patient reported outcomes, expanding expedited and conditional review pathways for the treatment not only for cancers, but for a broad spectrum of serious and life-threatening diseases, we must care more than ever about pharmacovigilance via more regular and creative risk management plans to be sure, but also through a more diligent effort to understand just what “safety and surveillance” is about in the 21st century. At least part of the solution lies with something called “Artificial Intelligence.”
Keywords:Pharmacovigilance ,Artificial Intelligence ,Drug Safety ,en ,